Dumais Michael R 4
4 · RAYTHEON TECHNOLOGIES CORP · Filed Mar 1, 2022
Insider Transaction Report
Form 4
Dumais Michael R
President, Hamilton Sundstrand
Transactions
- Disposition to Issuer
Common Stock
2022-02-25$97.73/sh−11,117$1,086,464→ 67,390 total - Sale
Common Stock
2022-02-28$101.48/sh−2,443$247,925→ 78,761 total - Exercise/Conversion
Common Stock
2022-02-25$83.58/sh+13,000$1,086,540→ 85,390 total - Exercise/Conversion
Common Stock
2022-02-28$83.58/sh+13,814$1,154,574→ 81,204 total - Sale
Common Stock
2022-02-25$97.76/sh−1,883$184,084→ 83,507 total - Sale
Common Stock
2022-02-25$97.73/sh−5,000$488,655→ 78,507 total - Disposition to Issuer
Common Stock
2022-02-28$101.53/sh−11,371$1,154,498→ 62,390 total - Exercise/Conversion
Stock Appreciation Right
2022-02-25−13,000→ 13,814 totalExercise: $83.58From: 2017-01-02Exp: 2024-01-01→ Common Stock (13,000 underlying) - Exercise/Conversion
Stock Appreciation Right
2022-02-28−13,814→ 0 totalExercise: $83.58From: 2017-01-02Exp: 2024-01-01→ Common Stock (13,814 underlying) - Sale
Common Stock
2022-02-28$101.43/sh−5,000$507,170→ 73,761 total
Holdings
- 1,879(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.